Abstract
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Five-fluorouracil (5FU) remains the single most effective treatment for advanced disease, despite a response rate of only 20%. Herein, we show that the antioxidants pyrrolidinedithiocarbamate and vitamin E induce apoptosis in CRC Cells. This effect is mediated by induction of p21WAF1/CIP1, a powerful inhibitor of the Cell cycle, through a mechanism involving C/EBPβ (a member of the CCAAT/enhancer binding protein family of transcription factors), independent of p53. Antioxidants significantly enhance CRC tumor growth inhibition by cytotoxic chemotherapy in vitro (5FU and doxorubicin) and in vivo (5FU). Thus, chemotherapeutic agents administered in the presence of antioxidants may provide a novel therapy for colorectal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parker, S.L. et al. Cancer statistics. CA Cancer J. Clin. 46, 5–27 (1996).
Symonds, H. et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703–711 (1994)
Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J. Clin. Oncol. 10, 896–903 (1992).
Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).
Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49–53 (1991).
Levine, A., Momand, J. & Finlay, C.A. p53 tumor suppressor gene. Nature 351, 453–456 (1991).
Boyle, P., Zaridze, D.G. & Smans, M. Descriptive epidemiology of colorectal cancer. Int. J. Cancer 36, 9–18 (1985).
Byers, T. & Perry, G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu. Rev. Nutr. 12, 139–159 (1992).
Stone, W.L. & Papas, A.M. Tocopherols and the etiology of colon cancer. J. Norl. Cancer Inst. 89, 1006–1014 (1997).
Greenwald, P., Kelloff, G.J., Burch-Whitman, C. & Kramer, B.S. Chemoprevention. CA Cancer. J. Clin. 45, 31–49 (1995).
Turley, J.M. et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor β. Cell. Growth Differ. 6, 655–663 (1995).
Tsai, J.C. et al. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetyl-cysteine in vascular smooth muscle cells. J. Biol. Chem. 271, 3667–3670 (1996).
Church, S.L. et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Notl. Acad. Sci. USA 90, 3313–3317 (1993).
Rautalahti, M. & Antioxidants and carcinogenesis. Ann. Med. 25, 435–441 (1993).
Irani, K. et al. Mitogenic signaling mediated by oxidants in ras-transformed fibrob-lasts. Science 275, 1649–1652 (1997).
Herrmann, R. Biochemical modulation of 5-fluorouracil. Cancer Treat. Rev. 17, 51–55 (1990).
Cummings, J. Anderson, L., Willmott, N. & Smyth, J.F. The molecular pharmacology of doxorubicin in vivo. Eur. J. Cancer 27, 532–535 (1991).
Peters, G.J. et al. Thymidylate synthase and drug resistance. Eur. J. Concer 31, 1299–1305 (1995).
Bendich, A. & Machlin, L.J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48, 612–619 (1988).
Sunderman, F.W. Therapeutic properties of sodium diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 21, 70–81 (1991).
Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G, cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
Gorospe, M., Wang, X., Guyton, K.Z. & Holbrook, N.J. Protective role of p21 (Waf 1 /Cip1) against prostaglandin A2-mediated apoptosis in human colorectal cancer cells. Mol. Cell. Biol. 16, 6654–6660 (1996).
Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996).
Wang, J. & Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359–361 (1996).
Wu, G.S. & EI-Deiry, W.S. Apoptotic death of tumor cells correlates with chemosensitivity of p53 or Bcl-2. Clin. Cancer Res. 2, 623–633 (1996).
Prahbu, N.S. et al. Suppression of cancer cell growth by adenovirus expressing p21WAF1/CIP1deficient in PCNA interaction. Clin. Cancer Res. 2, 1221–1230 (1996).
Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. & Howley, P.M. The E6 onco-protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990).
Kubbutat, M.H.G. & Vousden, K.H. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin. Viral. 7, 295–304 (1996).
Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).
EI-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
Landschulz, W.H., Johnson, P.F., Adahi, E.Y., Graves, B.J. & McKnight, S.L. Isolation of a recombinant copy of the gene encoding C/EBP gene. Genes Dev, 2, 786–800 (1988).
Akira, S. et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBOJ. 9, 1897–1906 (1990).
Poli, V., Mancini, F.P. & Cortese, R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643–653 (1990).
Cao, Z., Umek, R.M. & McKnight, S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538–1552 (1991).
Williams, S.C., Cantwell, C.A. & Johnson, P.F. A family of C/EBP-related proteins capable of forming covalently linked leucine zippers dimers in vitro. Genes Dev. 5, 1553–1567 (1991).
Akira, S. & Kishimot, T. IL-6 and NF-IL6 in acute-phase response to viral infection. Immunol. Rev. 127, 25–50 (1992).
Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1 /CIP-1 /SDI-1) protein. Genes Dev. 10, 804–815 (1996).
Isshiki, H. et al. Constitutive and interleukin-1 (IL-l)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol. Cell. Biol. 10, 2757–2764 (1990).
Vasseur-Cognet, M. & Lane, M.D. Trans-acting factors involved in adipogenic differentiation. Curr. Opin. Gen. Dev. 3, 238–245 (1993).
Beg, A.A. & Baltimore, D. An essential role of NF-κB in preventing TNF—induced cell death. Science 274, 782–784 (1996).
Wang, C.Y., Mayo, M.W. & Baldwin, A.S. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784–787 (1996).
Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787–789 (1996).
Grimm, S., Bauer-Manuel, K.A., Baeuerle, P.A. & Schulze, K.O. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell. Biol. 134, 13–23 (1996).
Schreck, R., Grassmann, R., Fleckenstein, B. & Baeuerle, P.A. Antioxidants selectively suppress activation of NF-kappaB by human T-cell leukemia virus type I Tax protein. J. Virol. 66, 6288–6298 (1992).
Traenckner, E.B. et al. Phosphorylation of human I kappaB-alpha on serines 32 and 36 controls I kappaB-alpha proteolysis and NF-kappaB activation in response to diverse stimuli. EMBO J. 14, 2876–2883 (1995).
Perkins, N.D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527 (1997).
Harper, J.W., Hannon, G.J., Zhang, H., Casso, D. & Elledge, S.J. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).
Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).
Deng, C., Zhang, P., Harer, W.J., Elledge, S.J. & Leder, P. Mice lacking p21WAF1/CIP1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
Hunter, T. & Pines, J. Cyclins and cancer: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).
Lemarie, E., Musset, M., Charbonnier, C., Renoux, M. & Renoux, G. Clinical characterization of Imuthipl. Methods Exp. Clin. Pharmacol. 8, 51–54 (1986).
Reisinger, E. et al. Inhibition of AIDS progression by dithiocarb. Lancet 335, 679–682 (1990).
Danielson, P.E. et al. p1b15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7, 261–267 (1988).
Kapiloff, M.S., Farkash, Y., Wegner, M. & Rosenfeld, M.G. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253, 786–789 (1991).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chinery, R., Brockman, J., Peeler, M. et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ. Nat Med 3, 1233–1241 (1997). https://doi.org/10.1038/nm1197-1233
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1197-1233
This article is cited by
-
Endogenous formaldehyde scavenges cellular glutathione resulting in redox disruption and cytotoxicity
Nature Communications (2022)
-
Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound
Journal of Experimental & Clinical Cancer Research (2016)
-
Motif co-regulation and co-operativity are common mechanisms in transcriptional, post-transcriptional and post-translational regulation
Cell Communication and Signaling (2015)
-
Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil
Archives of Toxicology (2015)
-
Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival
Molecular Cancer (2014)